Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04142619
Title Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.